(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:
Type 2 Diabetes
This study will evaluate the safety and effectiveness of adding an additional FDA-approved medication for diabetics who cannot control glucose levels.
The research site is in Houston, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
-----
Diabetic Neuropathy
This study is for people with diabetic neuropathy. The trial will last 15 weeks to one year, and includes up to 14 outpatient visits.
The research site is in Evansville, Ind.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
-----
Epilepsy
This study is for people diagnosed with partial epilepsy. It will include bi-weekly-to-monthly visits include meeting with neurologist, vitals, ecg's, and possible blood draw.
The research site is in Torrance, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/epilepsy.aspx.
-----
Diabetes Mellitus, Type 2
If you are an adult with type 2 diabetes, you may qualify for this study.
The research site is in Winston-Salem, N.C.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=603.
-----
Alzheimer's Disease
If you or a loved one are aged 40 to 85 with mild Alzheimer's disease, you or the loved one may qualify for this study.
The research site is in Boulder, Colo.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=11.
-----
Eczema (Atopic Dermatitis)
If you are an adult with moderate-to-severe atopic dermatitis (eczema), you may qualify for this study.
The research site is in Madison, Wis.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=211.
-----
Copyright 2009 ClinicalConnection.com and CenterWatch. All rights reserved.
